Veeda Clinical Research
Ticker > Company >

Veeda Clinical Research share price

Veeda Clinical Research Ltd.

 1.49 K   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year-4.73%
3 Year5.43%
5 Year11.65%

Profit Growth

1 Year-473.45%
3 Year-185.41%
5 Year-404.92%

ROE%

1 Year-1.21%
3 Year1.53%
5 Year15.69%

ROCE %

1 Year-1.02%
3 Year3%
5 Year15.68%

Debt/Equity

0

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of -185.406970178995% for the Past 3 years.
  • The company has shown a poor revenue growth of 5.43007992573412% for the Past 3 years.
  • Company has a poor ROE of 1.52973333333333% over the past 3 years.
  • Company has a poor ROCE of 2.99883333333333% over the past 3 years
  • Company has contingent liabilities of 759.067 Cr.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 195.81 223.93 296.15 275.45 262.43
Total Expenditure 129.1 182.85 241.74 247.49 256.95
Operating Profit 66.72 41.08 54.42 27.96 5.48
Other Income 38.57 4.23 9.15 17.56 21.84
Interest 4.81 4.58 5.33 5.87 5.34
Depreciation 14.95 15.53 21.13 35.02 37.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 85.53 25.2 37.1 4.63 -15.04
Tax 22.25 6.87 11.15 1.57 -3.62
Net Profit 63.29 18.33 25.95 3.06 -11.42
Adjusted EPS (Rs.) 17.55 3.47 4.91 0.49 -1.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 35.83 10.58 10.58 12.6 13.16
Total Reserves 133.93 463.18 510.6 879.44 999.18
Borrowings 0 0 0 0 0
Other N/C liabilities 34.8 27.48 34.54 48.35 55.18
Current liabilities 74.75 88.68 96.4 89.16 86.92
Total Liabilities 279.31 589.91 652.11 1029.55 1154.43
Assets
Net Block 74.36 69.7 105.72 162.49 149.6
Capital WIP 0.46 8.84 4.69 6.32 8.92
Intangible WIP 0.67 1.37 3.32 0.11 0.18
Investments 37.02 165.13 213.15 510 725.93
Loans & Advances 41.38 26.02 25.91 30.9 31.41
Other N/C Assets 4.89 13.7 36.51 11.08 2.38
Current Assets 120.52 305.16 262.82 308.65 236.02
Total Assets 279.31 589.91 652.11 1029.55 1154.43
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 85.53 25.2 37.1 4.63 -15.04
Adjustment 18.34 20.9 32.45 28.75 48.08
Changes in Assets & Liabilities -4.22 -21.41 19.07 -9.59 -19
Tax Paid -23.03 -11.96 -13.55 -3.26 0.08
Operating Cash Flow 76.63 12.73 75.06 20.52 14.11
Investing Cash Flow -93.15 -142.07 -107.61 -229.12 3.94
Financing Cash Flow 17.07 172.1 8.15 195.88 -17.55
Net Cash Flow 0.55 42.76 -24.4 -12.73 0.5

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Veeda Clinical Research
X